Zlatko Kopecki – Innovation in Data Analysis – Best Researcher Award 

Dr. Zlatko Kopecki - Innovation in Data Analysis - Best Researcher Award 

University of South Australia - Australia

Author Profile

Early Academic Pursuits

Dr. Zlatko Kopecki's academic journey began with his role as a Technical Officer in Histopathology at Clinpath Laboratories from 2003 to 2005, followed by a position as a Medical Scientist in Histopathology at Adelaide Pathology Partners from 2005 to 2011. During this period, he honed his skills in laboratory medicine, culminating in earning the Terumo Prize for Excellence in Laboratory Medicine with Honours from the University of South Australia (UniSA) in 2007. His dedication to his field was further recognized with a Dean’s Commendation for the quality of his Ph.D. thesis at the University of Adelaide in 2011.

Professional Endeavors

Dr. Kopecki's professional career is marked by several notable appointments. From 2010 to 2012, he served as a Research Officer at the Women’s and Children’s Hospital, where he began to establish his research credentials. His trajectory continued with a National Health and Medical Research Council (NHMRC) Early Career Researcher (ECR) Fellowship at UniSA from 2012 to 2015, during which he also held an honorary research fellowship at Queen Mary University of London. He progressed to the role of Senior Research Fellow at UniSA's Future Industries Institute (FII) from 2015 to 2021. His international engagements included visiting research fellowships at the University of Freiburg (2010), University of Lübeck (2017), and the University of Bath (2020).

Contributions and Research Focus

Dr. Kopecki's research has consistently focused on innovative approaches to wound management and therapy for rare skin diseases, particularly Epidermolysis Bullosa (EB). He has pioneered the development of biofilm-disrupting technologies and stimuli-responsive wound dressings, as well as antimicrobial photodynamic therapy (aPDT). His work also includes the development of antiseptic wound cleansers, medicated hydrogels, and antimicrobial materials for treating infections. His research employs various animal models to answer critical questions about wound infection and skin diseases, contributing significantly to product development and commercialization pathways.

Accolades and Recognition

Dr. Kopecki's contributions to research and patient advocacy have been recognized with numerous awards. Notable among these are the Young Investigator of the Year Award from the Australasian Wound & Tissue Repair Society (AWTRS) in 2016 and the Tall Poppy Award for outstanding scientific achievements in South Australia in 2017. His innovative research has also earned him prestigious grants, including multiple NHMRC Ideas Grants and the Alexander von Humboldt Fellowship for Experienced Researchers (2024-2026).

Impact and Influence

Dr. Kopecki's influence extends beyond his research to impactful patient advocacy. Since 2009, he has been actively involved with DEBRA (an international patient support organization for those affected by EB), where he has held various leadership positions. His efforts have led to significant initiatives, such as the National EB Dressing Scheme in Australia and the In Home Nurse Program, which have greatly improved patient care. His work with DEBRA International during the Ukrainian conflict highlights his commitment to global patient advocacy, providing essential support to EB patients affected by the war.

Legacy and Future Contributions

Dr. Kopecki's legacy is marked by his dedication to improving the lives of those with rare skin diseases through both research and advocacy. His innovative approaches in developing new therapies and his active role in patient support programs have set new standards in the field. Looking forward, Dr. Kopecki aims to continue his pioneering research, focusing on translating his findings into clinical practice to benefit patients worldwide. His ongoing collaborations with industry partners and his involvement in global patient advocacy programs ensure that his work will continue to have a significant impact on the field of wound management and rare skin diseases.

Citations

A total of 1592 citations for his publications, demonstrating the impact and recognition of her research within the academic community.

Esmail El-Fakharany – Innovation in Data Analysis – Best Researcher Award 

Prof. Esmail El-Fakharany - Innovation in Data Analysis - Best Researcher Award 

city of scientific research and technological applications - Egypt

Author Profile

Early Academic Pursuits

Prof. Esmail Mohammed El-Fakharany embarked on his academic journey with a strong foundation in the sciences, obtaining his Bachelor's degrees in Microbiology and Chemistry from esteemed institutions such as Al Azhar University and Mynofia University in Egypt. His passion for understanding the intricacies of microbial life led him to pursue further studies, culminating in a Diploma of Public Health in Microbiology and subsequent Master's and Ph.D. degrees in Microbiology from Al Azhar University.

During his academic pursuits, El-Fakharany demonstrated exceptional dedication and scholarly aptitude, evidenced by his excellent academic records and research endeavors. His Master's thesis focused on the antiviral activity of natural purified proteins, while his Ph.D. research delved into the study of antiviral activity in lactoferrin, showcasing his early commitment to exploring the potential of natural compounds in combating viral infections.

Professional Endeavors

Prof. El-Fakharany's professional journey has been marked by progressive roles within the City of Scientific Research and Technological Applications (SRTA-City), particularly within the Genetic Engineering and Biotechnology Research Institute. Starting as a Lab Specialist, he steadily climbed the academic ranks, serving as a Research Assistant, Assistant Professor, and ultimately, Associate Professor.

His tenure at SRTA-City has been characterized by significant contributions to research and academia, with a particular emphasis on microbiology, biotechnology, and cancer research. His roles have involved supervising both Master's and Ph.D. students, reflecting his commitment to nurturing the next generation of scientists.

Contributions and Research Focus

Prof. El-Fakharany's research portfolio spans a diverse array of topics, including antiviral agents, cancer therapeutics, immunology, and nanotechnology. His investigations into the antiviral properties of natural compounds have yielded promising results, as evidenced by numerous publications in reputable journals.

Of particular note is his pioneering work on the antiviral activity of lactoferrin-coated nanoparticles, which has significant implications for combatting viral infections such as COVID-19. Additionally, his studies on the development of novel anticancer agents and eco-friendly antimicrobial technologies underscore his commitment to addressing pressing global health challenges.

Accolades and Recognition

Prof. El-Fakharany's contributions to science have been recognized through prestigious awards and accolades, including the State Encouragement Award in Advanced Technologies from the Egyptian Academy of Science and Technology. Furthermore, his receipt of certificates for research contributions and scientific achievements underscores the impact of his work within the scientific community.

Impact and Influence

Prof. El-Fakharany's research has made a tangible impact on scientific knowledge and has the potential to translate into practical solutions for societal challenges. His publications in esteemed journals and participation in funded research projects attest to the relevance and significance of his findings in fields such as virology, cancer biology, and environmental science.

Legacy and Future Contributions

As El-Fakharany continues to pursue excellence in research and academia, his legacy is poised to endure through the students he has mentored, the discoveries he has made, and the innovations he has championed. His ongoing dedication to advancing scientific knowledge and addressing global health concerns ensures that his contributions will continue to shape the trajectory of scientific inquiry for years to come.